Montag A & Associates Inc. lessened its position in CME Group Inc (NASDAQ:CME) by 65.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,526 shares of the financial services provider’s stock after selling 4,700 shares during the period. Montag A & Associates Inc.’s holdings in CME Group were worth $369,000 as of its most recent filing with the SEC.
Several other large investors have also recently modified their holdings of CME. Valeo Financial Advisors LLC acquired a new stake in shares of CME Group in the 3rd quarter valued at $124,000. Bank of Nova Scotia Trust Co. acquired a new stake in shares of CME Group in the 3rd quarter valued at $165,000. SeaCrest Wealth Management LLC acquired a new stake in shares of CME Group in the 4th quarter valued at $203,000. LaFleur & Godfrey LLC acquired a new stake in shares of CME Group in the 3rd quarter valued at $204,000. Finally, Wesbanco Bank Inc. acquired a new stake in shares of CME Group in the 4th quarter valued at $205,000. Institutional investors own 82.85% of the company’s stock.
Several equities research analysts have recently commented on CME shares. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, October 25th. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price on the stock in a research note on Tuesday, January 2nd. Berenberg Bank began coverage on CME Group in a report on Thursday, January 25th. They issued a “hold” rating and a $170.00 price target for the company. Citigroup reaffirmed a “buy” rating and issued a $172.00 price target (up from $155.00) on shares of CME Group in a report on Monday, January 29th. Finally, Sandler O’Neill reaffirmed a “buy” rating and issued a $175.00 price target on shares of CME Group in a report on Friday, February 2nd. Three equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. CME Group has an average rating of “Buy” and a consensus target price of $157.00.
In other CME Group news, CFO John W. Pietrowicz sold 7,500 shares of the business’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $151.50, for a total transaction of $1,136,250.00. Following the completion of the sale, the chief financial officer now directly owns 32,376 shares of the company’s stock, valued at approximately $4,904,964. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ronald A. Pankau sold 200 shares of the business’s stock in a transaction dated Wednesday, February 14th. The stock was sold at an average price of $159.91, for a total value of $31,982.00. Following the sale, the director now directly owns 3,809 shares of the company’s stock, valued at $609,097.19. The disclosure for this sale can be found here. Insiders have sold a total of 64,728 shares of company stock valued at $9,755,257 over the last three months. Company insiders own 0.57% of the company’s stock.
CME Group Inc (NASDAQ:CME) opened at $162.38 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.03 and a debt-to-equity ratio of 0.10. CME Group Inc has a twelve month low of $114.82 and a twelve month high of $165.35. The stock has a market capitalization of $55,065.49, a PE ratio of 34.11, a P/E/G ratio of 2.10 and a beta of 0.64.
CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.10 by $0.02. CME Group had a return on equity of 7.68% and a net margin of 111.49%. The business had revenue of $900.00 million during the quarter, compared to analysts’ expectations of $886.85 million. During the same period in the previous year, the business posted $1.14 earnings per share. The firm’s revenue for the quarter was down 1.4% compared to the same quarter last year. research analysts predict that CME Group Inc will post 6.32 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 26th. Shareholders of record on Friday, March 9th will be issued a dividend of $0.70 per share. This is a boost from CME Group’s previous quarterly dividend of $0.66. This represents a $2.80 annualized dividend and a yield of 1.72%. The ex-dividend date of this dividend is Thursday, March 8th. CME Group’s payout ratio is currently 22.11%.
COPYRIGHT VIOLATION NOTICE: This report was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another publication, it was illegally stolen and republished in violation of US and international trademark & copyright law. The original version of this report can be accessed at https://ledgergazette.com/2018/02/18/cme-group-inc-cme-stake-lowered-by-montag-a-associates-inc.html.
CME Group Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.